| Decipher Labs Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524752 |
NSE Symbol : - |
P/E(TTM) : 396.50 |
|
ISIN Demat : INE643N01012 |
Div & Yield% : - |
EPS(TTM) : 0.04 |
|
Book Value(₹) : 8.65 |
Market Cap(₹Cr) : 16.02 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 0.08 | 0.38 | 3.36 | 0.17 | 0.00 | 0.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 0.08 | 0.38 | 3.36 | 0.17 | 0.00 | 0.00 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.02 | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 |
| Total Income | 0.10 | 0.39 | 3.36 | 0.18 | 0.01 | 0.01 |
| Total Expenditure | 0.15 | 0.51 | 3.23 | 0.08 | 0.09 | 0.11 |
| PBIDT | -0.05 | -0.12 | 0.13 | 0.10 | -0.09 | -0.10 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | -0.05 | -0.12 | 0.13 | 0.10 | -0.09 | -0.10 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 | 0.02 |
| Reported Profit After Tax | -0.06 | -0.13 | 0.13 | 0.09 | -0.07 | -0.12 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -0.06 | -0.13 | 0.13 | 0.09 | -0.07 | -0.12 |
| EPS (Unit Curr.) | -0.06 | -0.13 | 0.13 | 0.09 | -0.07 | -0.12 |
| EPS (Adj) (Unit Curr.) | -0.06 | -0.13 | 0.13 | 0.09 | -0.07 | -0.12 |
| Calculated EPS (Unit Curr.) | -0.06 | -0.13 | 0.13 | 0.09 | -0.07 | -0.12 |
| Calculated EPS (Adj) (Unit Curr.) | -0.06 | -0.13 | 0.13 | 0.09 | -0.07 | -0.12 |
| Calculated EPS (Ann.) (Unit Curr.) | -0.22 | -0.52 | 0.52 | 0.37 | -0.30 | -0.48 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -0.22 | -0.52 | 0.52 | 0.37 | -0.30 | -0.48 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 10.10 | 10.10 | 10.10 | 10.10 | 10.10 | 10.10 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -62.50 | -31.58 | 3.87 | 58.82 | 0.00 | 0.00 |
| PBDTM(%) | -62.50 | -31.58 | 3.87 | 58.82 | 0.00 | 0.00 |
| PATM(%) | -75.00 | -34.21 | 3.87 | 52.94 | 0.00 | 0.00 |